Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
C van Walraven a Clinical Epidemiology Unit, Ottawa Health
Research Institute, Ottawa Hospital - Civic Campus, Ottawa, ON, Canada
K1Y 4E9, b Institute for Clinical Evaluative Sciences, Toronto, ON,
Canada M4N 3M5, c Toronto Rehabilitation Institute, Toronto, ON, Canada M5G
2A2
Correspondence to: C van Walraven carlv{at}ohri.ca
Objectives:
To determine the association between
inhibition of serotonin reuptake by antidepressants and upper
gastrointestinal bleeding.
What is already known on this topic
What this study adds
Design:
Retrospective cohort study from population based databases.
Setting:
Ontario, Canada.
Participants:
317 824 elderly people observed for
more than 130 000 person years. The patients started taking an
antidepressant between 1992 and 1998 and were grouped by how much the
drug inhibited serotonin reuptake. Patients were observed until they
stopped the drug, had an upper gastrointestinal bleed, or died or the study ended.
Main outcome measure:
Admission to hospital for acute
upper gastrointestinal bleeding.
Results:
Overall, 974 bleeds were observed, with
an overall bleeding rate of 7.3 per 1000 person years. After
controlling for age or previous gastrointestinal bleeding, the risk of
bleeding significantly increased by 10.7% and 9.8%, respectively,
with increasing inhibition of serotonin reuptake. Absolute differences in bleeding between antidepressant groups were greatest for
octogenarians (low inhibition of serotonin reuptake, 10.6 bleeds/1000
person years v high inhibition of serotonin reuptake, 14.7 bleeds/1000 person years; number needed to harm 244) and those with
previous upper gastrointestinal bleeding (low, 28.6 bleeds/1000 person years v high, 40.3 bleeds/1000 person years; number needed
to harm 85).
Conclusions:
After age or previous upper
gastrointestinal bleeding were controlled for, antidepressants with
high inhibition of serotonin reuptake increased the risk of upper
gastrointestinal bleeding. These increases are clinically important for
elderly patients and those with previous gastrointestinal bleeding.
A case-control study found that the risk of upper gastrointestinal
bleeding increases with intake of antidepressants that extensively
inhibit serotonin reuptake
The risk of upper gastrointestinal bleeding in elderly and depressed
patients increases with antidepressants having the greatest extent of
inhibition of serotonin reuptake
namely, octogenarians and those with
previous upper gastrointestinal bleeding
The extent that an antidepressant inhibits serotonin reuptake should be
considered when drugs are required for depression in high risk
patients
Read all Rapid Responses